Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > bought deal

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Feb 04, 2021 12:35pm

141 Views

Post# 32471191

RE:RE:RE:RE:RE:bought deal

woundedknee wrote:
Reverse split is next...nasdaq...jmo

I disagree. However, it could be something relating to potential partnership deal where company X will invest a certain amount into SVA for some kind of license rights. Most often large corporations will not invest a lot of money into companies that don't have cash of their own on their books. It could also be a power move by Phil to show pharma we aren't desperate for their $. Or maybe it was just a really bad decision.

Time will tell.

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload